106 related articles for article (PubMed ID: 27083436)
21. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
22. COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.
Shah T; Press VG; Huisingh-Scheetz M; White SR
Chest; 2016 Oct; 150(4):916-926. PubMed ID: 27167208
[TBL] [Abstract][Full Text] [Related]
23. Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients.
Tse HN; Tseng CZ; Wong KY; Ng LY; Lai TL; Yee KS
Lung; 2016 Aug; 194(4):665-73. PubMed ID: 27140193
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
[TBL] [Abstract][Full Text] [Related]
25. COPD biomarkers as tools for decision making in early clinical drug development.
Taib Z; Jauhiainen A
Biomark Med; 2016 May; 10(5):513-24. PubMed ID: 27128658
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis.
Jonkman NH; Westland H; Trappenburg JC; Groenwold RH; Bischoff EW; Bourbeau J; Bucknall CE; Coultas D; Effing TW; Epton M; Gallefoss F; Garcia-Aymerich J; Lloyd SM; Monninkhof EM; Nguyen HQ; van der Palen J; Rice KL; Sedeno M; Taylor SJ; Troosters T; Zwar NA; Hoes AW; Schuurmans MJ
Eur Respir J; 2016 Jul; 48(1):55-68. PubMed ID: 27126694
[TBL] [Abstract][Full Text] [Related]
27. Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection.
Hinks TS; Wallington JC; Williams AP; Djukanović R; Staples KJ; Wilkinson TM
Am J Respir Crit Care Med; 2016 Nov; 194(10):1208-1218. PubMed ID: 27115408
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial.
Pinto EH; Longo PL; de Camargo CC; Dal Corso S; Lanza Fde C; Stelmach R; Athanazio R; Fernandes KP; Mayer MP; Bussadori SK; Mesquita Ferrari RA; Horliana AC
BMJ Open; 2016 Apr; 6(4):e010564. PubMed ID: 27084279
[TBL] [Abstract][Full Text] [Related]
29. Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.
Sridhar S; Liu H; Pham TH; Damera G; Newbold P
Respir Res; 2019 Jan; 20(1):14. PubMed ID: 30658649
[TBL] [Abstract][Full Text] [Related]
30. Assessment of NLRP3 inflammasome activation in patients with chronic obstructive pulmonary disease before and after lung transplantation.
Rumora L; Markelić I; Hlapčić I; Tomašković AH; Fabijanec M; Džubur F; Samaržija M; Dugac AV
Immunol Res; 2024 May; ():. PubMed ID: 38811459
[TBL] [Abstract][Full Text] [Related]
31. Role of the Fungus
Coronado K; Herrada C; Rojas DA
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542124
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: A pilot study.
Morales-González F; Lira-Lucio JA; Falfán-Valencia R; Márquez-García JE; Abarca-Rojano E; Ramírez-Venegas A; Sansores RH; García-Gómez L; Hernández-Pérez A; Pérez-Rubio G
Immun Inflamm Dis; 2023 Apr; 11(4):e825. PubMed ID: 37102657
[TBL] [Abstract][Full Text] [Related]
33. Immunity against Moraxella catarrhalis requires guanylate-binding proteins and caspase-11-NLRP3 inflammasomes.
Enosi Tuipulotu D; Feng S; Pandey A; Zhao A; Ngo C; Mathur A; Lee J; Shen C; Fox D; Xue Y; Kay C; Kirkby M; Lo Pilato J; Kaakoush NO; Webb D; Rug M; Robertson AA; Tessema MB; Pang S; Degrandi D; Pfeffer K; Augustyniak D; Blumenthal A; Miosge LA; Brüstle A; Yamamoto M; Reading PC; Burgio G; Man SM
EMBO J; 2023 Mar; 42(6):e112558. PubMed ID: 36762431
[TBL] [Abstract][Full Text] [Related]
34. Pyroptosis and respiratory diseases: A review of current knowledge.
Sun J; Li Y
Front Immunol; 2022; 13():920464. PubMed ID: 36248872
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.
Sun W; Cao Z; Ma Y; Wang J; Zhang L; Luo Z
Int J Chron Obstruct Pulmon Dis; 2022; 17():1299-1310. PubMed ID: 35686213
[TBL] [Abstract][Full Text] [Related]
36. Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
D'Amato M; Iadarola P; Viglio S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628501
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.
Hoult G; Gillespie D; Wilkinson TMA; Thomas M; Francis NA
BMC Pulm Med; 2022 May; 22(1):194. PubMed ID: 35549921
[TBL] [Abstract][Full Text] [Related]
38. New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease.
Zhang J; Xu Q; Sun W; Zhou X; Fu D; Mao L
J Inflamm Res; 2021; 14():4155-4168. PubMed ID: 34471373
[TBL] [Abstract][Full Text] [Related]
39. High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis.
Chakrabarti A; Mar JS; Choy DF; Cao Y; Rathore N; Yang X; Tew GW; Li O; Woodruff PG; Brightling CE; Grimbaldeston M; Christenson SA; Bafadhel M; Rosenberger CM
ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34350278
[TBL] [Abstract][Full Text] [Related]
40. Oral Pathogen
Li Q; Wang H; Tan L; Zhang S; Lin L; Tang X; Pan Y
Front Cell Infect Microbiol; 2021; 11():643913. PubMed ID: 33816348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
